3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Fallopian Tube Neoplasms
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Adenocarcinoma Of Esophagus
4
Triple Negative Breast Neoplasms
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Pancreatic Cystic Neoplasm
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Laryngeal Neoplasms
1
Gallbladder Neoplasms
1
Interventions
Cyclophosphamide
9
fludarabine
7
Standard of Care
5
Mycophenolic Acid
5
Whole-Body Irradiation
4
Specimen Handling
4
Sirolimus
4
Mesna
4
Filgrastim
4
Practice Guidelines as Topic
3
Nivolumab
3
Melphalan
3
GSK2636771
3
venetoclax
2
trametinib
2
talquetamab
2
osimertinib
2
dabrafenib
2
X-Rays
2
Thiotepa
2
Tacrolimus
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
Busulfan
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
thymoglobulin
1
sapanisertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Taxes
×
30 days
×
Clear all
No trials found.